As ATM [32] and AURKA [30] have been reported to have a synthetic lethal interaction with ARID1A in CRC, we selected c-MET as a novel synthetic lethal target for ARID1A in CRC for follow-up studies. The gene discussed is MET; the disease is colorectal carcinoma.